Loading...

Submitting the form, please do not close the page and
ensure that your network is smooth to avoid the email being unable to be sent.

SCIENCE DEFINES AGELESS SKIN

CAGR of 10.6%
Seize the dermal fillers market!

 

The global hyaluronic acid-based dermal fillers makretsize was valued at USD 3.67 billion in 2022 and is expected to grow at CAGR of 10.6% from 2023 to 2030.

dermal filler injection-07
dermal filler injection-06

Why fill with Formaderm®?

1. Long-lasting, High Viscoelasticity

 

ECHA™ balanced cross-linking technology uses a special equalization device to unwind the tangled hyaluronic acid molecule chain and evenly disperse the cross-linking agent BDDE, resulting in a filler with uniform cross-linking, excellent viscoelasticity, and longevity.

dermal filler injection-08

2. Safety first, allergy-free

 

Formaderm features medical-grade hyaluronic acid from non-animal sources, which is highly biocompatible, ensuring high stability and eliminating the risks of diseases and contamination.

dermal filler injection-11
dermal filler injection-12

$1.65 M Clinical efficacy and safety:

Investing $1.65 million in clinical trials with comparable efficacy to the leading brand. Natural results immediately after injection with no adverse reactions.

<0.02% Ultra-low protein content:

Raw material inspection results <0.02% to ensure the safety of use. (Regulatory Standards <0.3%)

<0.125 ppm Low BDDE residue:

WASH purification process effectively eliminates excess impurities, reducing the residual BDDE cross-linking agent to near zero (<0.125 ppm).

3. Superior comfort, superior satisfaction

 

Comfortable injection experience (injection thrust < 20N): This feature enhances the safety and predictability of the injection procedure, providing a more comfortable and controlled injection experience for both physicians and patients during injection.

Quick results !

Partners with MBI